Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls

Exhaled nitric oxide (FENO) is a well-known, non-invasive airway biomarker. In patients with Cystic Fibrosis (CF) FENO is decreased. To understand if reduced FENO is primary related to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) dysfunction or an epiphenomenon of chronic inflammation,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2018-01, Vol.17 (1), p.105-108
Main Authors: Korten, Insa, Liechti, Margot, Singer, Florian, Hafen, Gaudenz, Rochat, Isabelle, Anagnostopoulou, Pinelopi, Müller-Suter, Dominik, Usemann, Jakob, Moeller, Alexander, Frey, Urs, Latzin, Philipp, Casaulta, Carmen
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Exhaled nitric oxide (FENO) is a well-known, non-invasive airway biomarker. In patients with Cystic Fibrosis (CF) FENO is decreased. To understand if reduced FENO is primary related to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) dysfunction or an epiphenomenon of chronic inflammation, we measured FENO in 34 infants with CF prior to clinical symptoms and in 68 healthy controls. FENO was lower in CF compared to controls (p=0.0006) and the effect was more pronounced in CF infants without residual CFTR function (p
ISSN:1569-1993
1873-5010
DOI:10.1016/j.jcf.2017.05.005